IGF-1 Receptor Inhibitors in Clinical Trials—Early Lessons

od Weroha, S. John, Haluska, Paul
Wydane 2008

IGF System in Cancer

od Weroha, S. John, Haluska, Paul
Wydane 2012

Investigation of factors affecting the efficacy of 3C23K, a human monoclonal antibody targeting MISIIR

od Gill, Sarah E., Zhang, Qing, Keeney, Gary L., Cliby, William A., Weroha, S. John
Wydane w Oncotarget (2017)

Quantifying Insulin Receptor Isoform Expression in FFPE Breast Tumors

od Harrington, Sean C., Weroha, S. John, Reynolds, Carol, Suman, Vera J., Lingle, Wilma L., Haluska, Paul
Wydane 2012

Targeting an autocrine IL-6 – SPINK1 signaling axis to suppress metastatic spread in ovarian clear cell carcinoma

od Mehner, Christine, Miller, Erin, Hockla, Alexandra, Coban, Mathew, Weroha, S. John, Radisky, Derek C., Radisky, Evette S.
Wydane w Oncogene (2020)

Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats

od Li, Jonathan J., Weroha, S. John, Lingle, Wilma L., Papa, Dan, Salisbury, Jeffrey L., Li, Sara Antonia
Wydane 2004

Conventional Chemotherapy and Oncogenic Pathway Targeting in Ovarian Carcinosarcoma Using a Patient-Derived Tumorgraft

od Glaser, Gretchen, Weroha, S. John, Becker, Marc A., Hou, Xiaonan, Enderica-Gonzalez, Sergio, Harrington, Sean C., Haluska, Paul
Wydane w PLoS One (2015)

Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer

od Becker, Marc A., Hou, Xiaonan, Tienchaianada, Piyawan, Haines, Brian B., Harrington, Sean C., Weroha, S. John, Sathyanarayanan, Sriram, Haluska, Paul
Wydane w BMC Cancer (2016)

Overcoming platinum resistance in ovarian cancer by targeting pregnancy-associated plasma protein-A

od Torres, Diogo, Hou, Xiaonan, Bale, Laurie, Heinzen, Ethan P., Maurer, Matthew J., Zanfagnin, Valentina, Oberg, Ann L., Conover, Cheryl, Weroha, S. John
Wydane w PLoS One (2019)

Frequent POLE-driven hypermutation in ovarian endometrioid cancer revealed by mutational signatures in RNA sequencing

od Davila, Jaime I., Chanana, Pritha, Sarangi, Vivekananda, Fogarty, Zachary C., Weroha, S. John, Guo, Ruifeng, Goode, Ellen L., Huang, Yajue, Wang, Chen
Wydane w BMC Med Genomics (2021)

Dual HER/VEGF receptor targeting inhibits in vivo ovarian cancer tumor growth

od Becker, Marc A., Farzan, Thahir, Harrington, Sean C., Krempski, James W., Weroha, S. John, Hou, Xiaonan, Kalli, Kimberly R., Wong, Tai W., Haluska, Paul
Wydane 2013

IGFBP ratio confers resistance to IGF targeting and correlates with increased invasion and poor outcome in breast tumors

od Becker, Marc A., Hou, Xiaonan, Harrington, Sean C., Weroha, S. John, Gonzalez, Sergio E., Jacob, Kristina A., Carboni, Joan M., Gottardis, Marco M., Haluska, Paul
Wydane 2012

Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts()()

od Butler, Kristina A., Hou, Xiaonan, Becker, Marc A., Zanfagnin, Valentina, Enderica-Gonzalez, Sergio, Visscher, Daniel, Kalli, Kimberly R., Tienchaianada, Piyawan, Haluska, Paul, Weroha, S. John
Wydane w Neoplasia (2017)

Gene expression differences between matched pairs of ovarian cancer patient tumors and patient-derived xenografts

od Liu, Yuanhang, Chanana, Pritha, Davila, Jaime I., Hou, Xiaonan, Zanfagnin, Valentina, McGehee, Cordelia D., Goode, Ellen L., Polley, Eric C., Haluska, Paul, Weroha, S. John, Wang, Chen
Wydane w Sci Rep (2019)

Phase II Trial of Lapatinib and Topotecan (LapTop) in Patients with Platinum-Refractory/Resistant Ovarian and Primary Peritoneal Carcinoma

od Weroha, S. John, Oberg, Ann L., Allen Ziegler, Katie L., Dakhilm, Shaker R., Rowland, Kendrith M., Hartmann, Lynn C., Moore, Dennis F., Keeney, Gary L., Peethambaram, Prema P., Haluska, Paul
Wydane 2011

Transcriptomic Characterization of Endometrioid, Clear Cell, and High Grade Serous Epithelial Ovarian Carcinoma

od Fridley, Brooke L., Dai, Junqiang, Raghavan, Rama, Li, Qian, Winham, Stacey J., Hou, Xiaonan, Weroha, S. John, Wang, Chen, Kalli, Kimberly R., Cunningham, Julie M., Lawrenson, Kate, Gayther, Simon A., Goode, Ellen L.
Wydane w Cancer Epidemiol Biomarkers Prev (2018)

Association of a novel endometrial cancer biomarker panel with prognostic risk, platinum insensitivity, and targetable therapeutic options

od Bosquet, Jesus Gonzalez, Zhang, Qing, Cliby, William A., Bakkum-Gamez, Jamie N., Cen, Ling, Dowdy, Sean C., Sherman, Mark E., Weroha, S. John, Clayton, Amy C., Kipp, Benjamin R., Halling, Kevin C., Couch, Fergus J., Podratz, Karl C.
Wydane w PLoS One (2021)

Loss of FOXO1 cooperates with TMPRSS2-ERG overexpression to promote prostate tumorigenesis and cell invasion

od Yang, Yinhui, Blee, Alexandra M., Wang, Dejie, An, Jian, Pan, Yunqian, Yan, Yuqian, Ma, Tao, He, Yundong, Dugdale, Joseph, Hou, Xiaonan, Zhang, Jun, Weroha, S. John, Zhu, Wei-Guo, Wang, Y. Alan, DePinho, Ronald A., Xu, Wanhai, Huang, Haojie
Wydane w Cancer Res (2017)

Characterization of fusion genes in common and rare epithelial ovarian cancer histologic subtypes

od Earp, Madalene A, Raghavan, Rama, Li, Qian, Dai, Junqiang, Winham, Stacey J., Cunningham, Julie M., Natanzon, Yanina, Kalli, Kimberly R., Hou, Xiaonan, Weroha, S. John, Haluska, Paul, Lawrenson, Kate, Gayther, Simon A., Wang, Chen, Goode, Ellen L., Fridley, Brooke L.
Wydane w Oncotarget (2017)

Nicotinamide mononucleotide prevents cisplatin-induced cognitive impairments

od Yoo, Ki Hyun, Tang, Jason J., Rashid, Mohammad Abdur, Cho, Chang Hoon, Corujo-Ramirez, Ana, Choi, Jonghoon, Bae, Mun Gyeong, Brogren, Danielle, Hawse, John R., Hou, Xiaonan, Weroha, S. John, Oliveros, Alfredo, Kirkeby, Lindsey A., Baur, Joseph A., Jang, Mi-Hyeon
Wydane w Cancer Res (2021)